New hope for elderly myeloma patients: drug combo aims for deep response without transplant
NCT ID NCT05572229
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study tests two drug combinations (teclistamab plus daratumumab or lenalidomide) in people aged 65 and older with newly diagnosed multiple myeloma who are not eligible for a stem cell transplant. The goal is to see if these combinations are safe and can achieve a very good partial response or better after four treatment cycles. About 74 participants will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aphp - Chu Henri Mondor
ACTIVE_NOT_RECRUITINGParis, France
-
Aphp - Hopital Saint Antoine
NOT_YET_RECRUITINGParis, France
Contact
-
Aphp - Hopital Saint Louis
NOT_YET_RECRUITINGParis, France
Contact
-
Aphp Hopital Avicenne
NOT_YET_RECRUITINGBobigny, France
Contact
-
Centre Hospitalier de La Cote Basque
RECRUITINGBayonne, France
Contact
-
Centre Hospitalier de Versailles
RECRUITINGLe Chesnay, France
Contact
-
Centre Leon Berard
NOT_YET_RECRUITINGLyon, France
Contact
-
Ch D'Avignon
ACTIVE_NOT_RECRUITINGAvignon, France
-
Ch de Dunkerque
ACTIVE_NOT_RECRUITINGDunkirk, France
-
Chr Metz-Thionville
RECRUITINGMetz, France
Contact
-
Chru Angers
RECRUITINGAngers, France
Contact
-
Chru Bretonneau
RECRUITINGTours, France
Contact
-
Chru de Nancy, Hopitaux de Brabois
RECRUITINGNancy, France
Contact
-
Chu Amiens - Hopital Sud
RECRUITINGAmiens, France
Contact
-
Chu Bordeaux
RECRUITINGPessac, France
Contact
-
Chu Dijon Bourgogne
RECRUITINGDijon, France
Contact
-
Chu Limoges
ACTIVE_NOT_RECRUITINGLimoges, France
-
Chu Montpellier
RECRUITINGMontpellier, France
Contact
-
Chu Pontchaillou
ACTIVE_NOT_RECRUITINGRennes, France
-
Chu de Besancon
RECRUITINGBesançon, France
Contact
-
Chu de Caen
RECRUITINGCaen, France
Contact
-
Chu de Grenoble
RECRUITINGLa Tronche, France
Contact
-
Chu de Lille, Hopital Claude Huriez
RECRUITINGLille, France
Contact
-
Chu de Nantes Site Hotel Dieu
ACTIVE_NOT_RECRUITINGNantes, France
-
Chu de Poitiers
RECRUITINGPoitiers, France
Contact
-
Chu de Reims
NOT_YET_RECRUITINGReims, France
Contact
-
Hopital E. Muller- Ghrmsa
NOT_YET_RECRUITINGMulhouse, France
Contact
-
Hopitaux Universitaire de Strasbourg - Hopital Hautepierre
RECRUITINGStrasbourg, France
Contact
-
Oncopole Chu Toulouse
RECRUITINGToulouse, France
Contact
Conditions
Explore the condition pages connected to this study.